Phase 1/2 Lyme Vaccine Study

NCT01504347 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

1630

Enrollment

INDUSTRY

Sponsor class

Conditions

Prophylaxis of Lyme Borreliosis

Interventions

BIOLOGICAL: Multivalent recombinant OspA Lyme Borreliosis Vaccine
BIOLOGICAL: Multivalent recombinant OspA Lyme Borreliosis Vaccine
BIOLOGICAL: Multivalent recombinant OspA Lyme Borreliosis Vaccine

Sponsor

Baxalta now part of Shire

Collaborators

[object Object]